Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal Cancer
Clinical trial NCT03693170 · COMPLETED
Trial details
- NCT number
- NCT03693170
- Sponsor
- Pierre Fabre Medicament
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-17
- Primary completion
- 2020-06-29
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.